LIPOCINE INC. Restricted Cash and Cash Equivalents
LIPOCINE INC. (LPCN) had Restricted Cash and Cash Equivalents of $5.00 million as of 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-03-09
- 2020-12-31: Restricted Cash and Cash Equivalents $5.00M.
- 2020-09-30: Restricted Cash and Cash Equivalents $5.00M.
- 2020-06-30: Restricted Cash and Cash Equivalents $5.00M.
- 2020-03-31: Restricted Cash and Cash Equivalents $5.00M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-12-31 | $5.00M 10-K · filed 2022-03-09 |
| 2020-09-30 | $5.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.00M 10-K · filed 2021-03-11 |
| 2019-09-30 | $5.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.00M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.00M 10-K · filed 2020-03-13 |
| 2018-09-30 | $5.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $5.00M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |